Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Bristol-Myers Squibb pulls FDA filing for asunaprevir, citing rapidly evolving hepatitis C field
Bristol-Myers Squibb pulls FDA filing for asunaprevir, citing rapidly evolving hepatitis C field
Bristol-Myers Squibb pulls FDA filing for asunaprevir, citing rapidly evolving hepatitis C field
Submitted by
admin
on October 7, 2014 - 8:48am
Source:
First Word Pharma
News Tags:
Bristol-Myers Squibb
asunaprevir
hepatitis C
Headline:
Bristol-Myers Squibb pulls FDA filing for asunaprevir, citing rapidly evolving hepatitis C field
Do Not Allow Advertisers to Use My Personal information
